Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis

Gao,Bo; Sun,Wang; Meng,Xianzhi; Xue,Dongbo; Zhang,Weihui

doi:10.3892/mmr.2016.5837

Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis

Authors:
- Bo Gao
- Wang Sun
- Xianzhi Meng
- Dongbo Xue
- Weihui Zhang
View Affiliations

Affiliations: Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: October 12, 2016 https://doi.org/10.3892/mmr.2016.5837
Pages: 4629-4637
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hematological abnormalities are frequently observed in patients with liver cirrhosis (LC). A previous study demonstrated that the apoptosis and damage of endothelial cells could cause the hematological abnormalities in LC. Protein kinases are one of the most important factors that regulate cell behavior, and are potential therapeutic targets for the treatment of a number of diseases. In a previous study, whole genome profiling was used to identify differentially expressed genes in human bone marrow endothelial cells treated with serum from 26 patients with LC. From this data set, the present study identified 14 differentially expressed kinase genes in human bone marrow endothelial cells in LC from the microarray data, including p38a, AKT1 and PDK1. Pathway analysis revealed that these kinase genes were enriched in certain important LC‑associated pathways (e.g. MAPK and WNT signaling pathway). Literature mining revealed that p38a was associated with bone marrow apoptosis; therefore, p38a and its inhibitor, SB203580, were selected as potential therapeutic targets in the present study. The results of hematoxylin‑eosin and Masson's trichrome staining of livers from a rat model of liver fibrosis (LF) that underwent ligation of the bile duct demonstrated that SB203580 reduced the degree of LF. In addition, SB203580‑treated rats with LF demonstrated a significantly higher number of platelets when compared with the untreated group. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis indicated that apoptosis of bone marrow tissue in rats with LF was inhibited by SB203580. In addition, the results from the immunohistochemical analysis demonstrated that SB203580 reduced the expression of von Willebrand factor and caspase 3 in the bone marrow of rats with LF. In conclusion, the results from the present study indicate that the p38a kinase inhibitor, SB203580, may exhibit a protective effect on bone marrow tissues in rats with LF. This suggests that protein kinases and their inhibitors may present novel therapeutic strategies for the treatment of hematological abnormalities in patients with LC.

View Figures

View References

1	Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, Ripoll C, Maurer R, Planas R, Escorsell A, et al: Incidence, prevalence, and clinical significance of abnormal hematological indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 7:689–695. 2009. View Article : Google Scholar : PubMed/NCBI
2	Rois R, Sangro B, Herrero I, Quiroga J and Prieto J: The role of thrombopoietin in the thrombocytopenia of patients with live cirrhosis. Am J Gastroenterol. 100:1131–1136. 2005.
3	Sheehy T and Berman A: The anemia of cirrhosis. J Lab Clin Med. 56:72–82. 1960.PubMed/NCBI
4	Mas VR, Fassnacht R, Archer KJ and Maluf D: Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med. 16:287–297. 2010. View Article : Google Scholar : PubMed/NCBI
5	Ramachandran R and Kakar S: Histological patterns in drug-induced liver disease. J Clin Pathol. 62:481–492. 2009. View Article : Google Scholar : PubMed/NCBI
6	Sullivan LW and Herbert V: Suppression of hematopoiesis by ethanol. J Clin Invest. 43:2048–2062. 1964. View Article : Google Scholar : PubMed/NCBI
7	Rosenfeld SJ and Young NS: Viruses and bone marrow failure. Blood Rev. 5:71–77. 1991. View Article : Google Scholar : PubMed/NCBI
8	Gao B, Wang D, Ma W, Jia X, Ma B, Zhang W and Xue D: MicroRNA-mRNA regulatory network study and apoptosis analysis on bone marrow endothelial cells induced by liver cirrhosis serum. Clin Res Hepatol Gastroenterol. 38:451–461. 2014. View Article : Google Scholar : PubMed/NCBI
9	Gao B, Sun W, Wang X, Jia X, Ma B, Chang Y, Zhang W and Xue D: Whole genome expression profiling and screening for differentially expressed cytokine genes in human bone marrow endothelial cells treated with humoral inhibitors in liver cirrhosis. Int J Mol Med. 32:1204–1214. 2013.PubMed/NCBI
10	Kopp HG, Avecilla ST, Hooper AT and Rafii S: The bone marrow vascular niche: Home of HSC differentiation and mobilization. Physiology (Bethesda). 20:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
11	Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, Moore MA and Asch AS: Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion. Blood. 84:10–19. 1994.PubMed/NCBI
12	Li WM, Huang WQ, Huang YH, Jiang DZ and Wang QR: Positive and negative haematopoietic cytokines produced by bone marrow endothelial cells. Cytokine. 12:1017–1023. 2000. View Article : Google Scholar : PubMed/NCBI
13	Hubbard SR and Till JH: Protein tyrosine kinase structure and function. Annu Rev Biochem. 69:373–398. 2000. View Article : Google Scholar : PubMed/NCBI
14	Manning G, Whyte DB, Martinez R, Hunter T and Sudarsanam S: The protein complement of the human genome. Science. 298:1912–1934. 2002. View Article : Google Scholar : PubMed/NCBI
15	Cheung CH, Coumar MS, Chang JY and Hsieh HP: Aurora kinase inhibitor patents and agents in clinical testing: An update (2009–10). Expert Opin Ther Pat. 21:857–884. 2011. View Article : Google Scholar : PubMed/NCBI
16	Zempleni J and Mock DM: Chemical synthesis of biotinylated histones and analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis/streptavidin-peroxidase. Arch Biochem Biophys. 371:83–88. 1999. View Article : Google Scholar : PubMed/NCBI
17	Chiu CT, Chen JH, Chou FP and Lin HH: Hibiscus sabdariffa leaf extract inhibits human prostate cancer cell invasion via down-regulation of Akt/NF-kB/MMP-9 pathway. Nutrients. 7:5065–5087. 2015. View Article : Google Scholar : PubMed/NCBI
18	Huang Y, Xia W, Lu M, Gao B, Qiao X, Sun B, Zhang W, Zhang Y and Xue D: Role of kinase epidermal growth factor receptor and SRC in the caerulein-induced acute pancreatitis in mice. Pancreas. 44:152–157. 2015. View Article : Google Scholar : PubMed/NCBI
19	Li Z, Ma B, Lu M, Qiao X, Sun B, Zhang W and Xue D: Construction of network for protein kinases that play a role in acute pancreatitis. Pancreas. 42:607–613. 2013. View Article : Google Scholar : PubMed/NCBI
20	Hofberger JA, Nsibo DL, Govers F, Bouwmeester K and Schranz ME: A complex interplay of tandem- and whole-genome duplication drives expansion of the L-type lectin receptor kinase gene family in the brassicaceae. Genome Biol Evol. 7:720–734. 2015. View Article : Google Scholar : PubMed/NCBI
21	Draghetti C, Salvat C, Zanoguera F, Curchod ML, Vignaud C, Peixoto H, Di Cara A, Fischer D, Dhanabal M, Andreas G, et al: Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallin. J Biol Chem. 284:32053–32065. 2009. View Article : Google Scholar : PubMed/NCBI
22	Zhao S, Fu YM, Li XF, Jin ZF, Zhao RB, Huang Q, Zhang FM and Zhang WH: Alterations of bone marrow sinusoidal endothelium in rat and patients with liver cirrhosis. Dig Dis Sci. 55:654–661. 2010. View Article : Google Scholar : PubMed/NCBI
23	Wagner DD and Frenette PS: The vessel wall and its interactions. Blood. 111:5271–5281. 2008. View Article : Google Scholar : PubMed/NCBI
24	Blann AD: von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci. 50:125–134. 1993.PubMed/NCBI
25	Gao B, Li ZT, Xue DB and Zhang WH: A novel mechanism of abnormal hematological indices in liver cirrhosis: Bone marrow endothelial cell dysfunction caused by humoral inhibitor affects the hematopoietic function of bone marrow. Med Hypotheses. 82:282–285. 2014. View Article : Google Scholar : PubMed/NCBI
26	Grossi V, Peserico A, Tezil T and Simone C: p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol. 20:9744–9758. 2014. View Article : Google Scholar : PubMed/NCBI
27	Ji RR, RW IV Gereau, Malcangio M and Strichartz GR: MAP kinase and pain. Brain Res Rev. 60:135–148. 2009. View Article : Google Scholar : PubMed/NCBI
28	Kevil CG, Oshima T and Alexander JS: The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium. 8:107–116. 2001. View Article : Google Scholar : PubMed/NCBI
29	Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ and Lee SJ: Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells. Mol Cell Endocrinol. 369:130–139. 2013. View Article : Google Scholar : PubMed/NCBI
30	Zhou L, Opalinska J and Verma A: p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle. 6:534–537. 2007. View Article : Google Scholar : PubMed/NCBI
31	Luo YH, Ouyang PB, Tian J, Guo XJ and Duan XC: Rosiglitazone inhibits TGF-β 1 induced activation of human Tenon fibroblasts via p38 signal pathway. PLoS One. 9:e1057962014. View Article : Google Scholar : PubMed/NCBI
32	Gressner AM and Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 10:76–99. 2006. View Article : Google Scholar : PubMed/NCBI
33	Wang M, Crisostomo PR, Herring C, Meldrum KK and Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 291:R880–R884. 2006. View Article : Google Scholar : PubMed/NCBI
34	Yu J, Eto M, Akishita M, Okabe T and Ouchi Y: A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells. Vascul Pharmacol. 51:21–28. 2009. View Article : Google Scholar : PubMed/NCBI
35	Nagila A, Netsawang J, Suttitheptumrong A, Morchang A, Khunchai S, Srisawat C, Puttikhunt C, Noisakran S, Yenchitsomanus PT and Limjindaporn T: Inhibition of p38MAPK and CD137 signaling reduce dengue virus-induced TNF-α secretion and apoptosis. Virol J. 10:1052013. View Article : Google Scholar : PubMed/NCBI
36	Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, Kaji K, Aihara Y, Nishimura N, Takeda K, et al: Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. Mol Med Rep. 11:1693–1700. 2015.PubMed/NCBI
37	Meng F, Meliton A, Moldobaeva N, Mutlu G, Kawasaki Y, Akiyama T and Birukova AA: Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 308:L452–L463. 2015. View Article : Google Scholar : PubMed/NCBI
38	Bühler S and Laufer SA: p38 MAPK inhibitors: A patent review (2012–2013). Expert Opin Ther Pat. 24:535–554. 2014. View Article : Google Scholar : PubMed/NCBI